RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Fairway, KS · Kansas City, KS · +42 more sites
Prostate Cancer clinical trials in Kansas City, KS
8 recruiting prostate cancer studies with a site in Kansas City, KS.
RecruitingPhase 2NCT07745361
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Sponsor: Monte Rosa Therapeutics, Inc
Kansas City, KS · +13 more sites
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Kansas City, KS · +17 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Kansas City, KS · +34 more sites
RecruitingPhase 1NCT07581184
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Aktis Oncology, Inc.
Kansas City, KS · +5 more sites
RecruitingPhase 3NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Sponsor: M.D. Anderson Cancer Center
Kansas City, KS · +5 more sites
RecruitingNot applicableNCT03802851
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
Sponsor: University of Kansas Medical Center
Kansas City, KS
Not yet recruitingPhase 2NCT06129851
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Sponsor: University of Kansas Medical Center
Kansas City, KS
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.